Society Meeting Presentations
33rd Annual Western Vascular Society Meeting, September 22-25, 2018
Comparison of Bovine Carotid Xenograft Versus Expanded Polytetrafluorethylene Grafts for Forearm Loop Hemodialysis Access
Benjamin Colvard, Kedar Lavignia, Vy T. Ho, Nathan Itoga, Anahita Dua, E John Harris, Matthew Mell, Manuel Garcia-Toc. Stanford University Hospitals, Stanford & San Jose, CA
Journal of Vascular Surgery, Volume 68, Number 3, September 2018
Secondary patency was significantly better with BCA compared with ePTFE and had similar infection rates in 57 forearm loop grafts.
Society for Vascular Surgery Annual Meeting, June 21-22, 2018
Bovine Carotid Graft as a Conduit in Arterial Trauma
Brendon Reilly, Raphael Blochle, James Lukan, Linda Harris, Maciej Dryjski, Monica S. O’Brien-Irr, Sikandar Z. Khan. University of Buffalo, NY
Journal of Vascular Surgery, Volume 67, Number 6, June 2018
BCAG is a suitable choice for blunt or penetrating traumatic arterial injuries when autologous tissue is not available, either owing to time constraints or absence of suitable conduit. There were no cases of graft or wound infection.
Vascular Access Society of the Americas (VASA) Symposium, May 2-3, 2014
Vascular Access Society of the Americas (VASA) Symposium, May 9-11, 2012
Dr. Marwan Tabbara, Vascular Access surgeon at the University of Miami Hospital and Jackson Memorial Hospital, presented on the topic, “Achieving Functional Status within 3.5 Months after Creation of Upper Extremity Arterio-venous Fistulas Using a Standardized Protocol.”
Disclaimer Of Medical Liability
ARTEGRAFT, INC. DOES NOT PROVIDE MEDICAL ADVICE. The content is for general informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Reliance on any information provided on this website is solely at your own risk. Individual medical needs are different; you should not assume that the information on this website concerning certain courses of treatment or outcomes will apply to you. Rather, you should evaluate your medical condition and make treatment decisions based upon consultation with your physician.
The contents of Artegraft’s website may be of interest to medical professionals or other health care providers. Such contents are for general informational purposes only and not intended to provide medical advice. Medical professionals and health care providers should exercise their own judgment in determining whether a particular product or procedure is appropriate for their practice or their patients.
Artegraft’s website contains information about products that currently are only available in the U.S.A. Nothing on this website should be construed as a solicitation for, or promotion of, any product or the use of any product that is not authorized in the U.S. under Federal laws and regulations.